Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cogentix Medical In (CGNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 234,504
  • Shares Outstanding, K 60,910
  • Annual Sales, $ 56,320 K
  • Annual Income, $ -880 K
  • 36-Month Beta 0.58
  • Price/Sales 4.16
  • Price/Cash Flow 98.24
  • Price/Book 3.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/01/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/18
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.82 +0.79%
on 04/20/18
3.92 -1.79%
on 04/04/18
+0.02 (+0.52%)
since 03/20/18
3-Month
2.51 +53.39%
on 02/06/18
3.92 -1.79%
on 04/04/18
+1.06 (+37.99%)
since 01/19/18
52-Week
1.55 +148.39%
on 05/17/17
3.92 -1.79%
on 04/04/18
+2.16 (+127.81%)
since 04/20/17

Most Recent Stories

More News
Global Bronchoscopes Market Analysis & Forecast (2018-2025): Teleflex, Olympus, Fujifilm, Boston Scientific, and Cogentix Medical are Dominating the $29.6 Billion Projected Market

The "Bronchoscopes Market Size, Share & Trends Analysis Report By Use (Reusable, Disposable), By Type (Flexible (Video, Fiberoptic, Hybrid), Rigid), By Region, And Segment Forecasts, 2018 - 2025" report...

CGNT : 3.85 (unch)
Cogentix Medical, Inc. / Laborie Medical Technologies Canada ULC Merger Litigation

TORONTO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- On March 11, 2018, Cogentix Medical, Inc. ("Cogentix") and certain affiliates of Laborie Medical Technologies Canada ULC ("Laborie"), LM US Parent, Inc. ("Parent")...

CGNT : 3.85 (unch)
Lifshitz & Miller LLP Announces Investigation of Bravo Brio Restaurant Group, Inc., Cogentix Medical, Inc., GGP Inc., iKang Healthcare Group, Inc., Klondex Mines Ltd., Orbotech Ltd. and Stewart Information Services Corporation

Bravo Brio Restaurant Group, Inc. (BBRG)

GGP : 22.06 (+0.59%)
STC : 41.12 (+0.15%)
CGNT : 3.85 (unch)
KLDX : 2.16 (-2.26%)
ORBK : 57.84 (-0.46%)
BBRG : 4.05 (+1.25%)
KANG : 17.66 (-0.51%)
IRMTF : 11.9721 (-0.40%)
LABORIE Medical Technologies and Cogentix Medical Announce Completion of Acquisition of Cogentix Medical by LABORIE Medical Technologies

LABORIE Medical Technologies ("LABORIE") and Cogentix Medical, Inc. (NASDAQ: CGNT) ("Cogentix") today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE'S affiliate Camden...

CGNT : 3.85 (unch)
Laborie Medical Technologies Announces Successful Completion of Tender Offer for Cogentix Medical, Inc.

Laborie Medical Technologies ("Laborie") announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of LM US Parent, Inc....

CGNT : 3.85 (unch)
Zacks.com featured highlights include: Ecopetrol, TheStreet, Cogentix, Fortuna Silver and CPI Aerostructures

Zacks.com featured highlights include: Ecopetrol, TheStreet, Cogentix, Fortuna Silver and CPI Aerostructures

FSM : 3.27 (-1.21%)
CVU : 6.68 (-0.30%)
TST : 2.04 (+0.99%)
CGNT : 3.85 (unch)
EC : 18.96 (-3.22%)
The Law Offices of Vincent Wong Reminds Investors of an Investigation into Cogentix Medical, Inc. in Connection with the Sale of the Company to LABORIE Medical Technologies

The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. ("Cogentix" or the "Company") (NASDAQCM:CGNT) for possible breaches of fiduciary duty and...

CGNT : 3.85 (unch)
5 Bargain Breakout Stocks Offering Amazing Returns

This involves zeroing in on stocks trading within a tight range and buying them when they step out of this band.

FSM : 3.27 (-1.21%)
CVU : 6.68 (-0.30%)
TST : 2.04 (+0.99%)
CGNT : 3.85 (unch)
EC : 18.96 (-3.22%)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Cogentix Medical, Inc.- CGNT

BALA CYNWYD, PA / ACCESSWIRE / April 6, 2018 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cogentix Medical, Inc. ("Cogentix"...

CGNT : 3.85 (unch)
Association of Black Cardiologists Announces New President, Board Chair and Executive Committee Members

The Association of Black Cardiologists (ABC), an inclusive organization dedicated to eliminating disparities in cardiovascular diseases, has recently installed John M. Fontaine, MD, MBA, FACC, FHRS as...

TCMD : 52.99 (-0.97%)
CGNT : 3.85 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CGNT with:

Business Summary

Cogentix Medical, Inc. is a medical device company which designs, develops, manufactures and markets proprietary technologies serving the urology market. The company's primary product consists of Urgent(R) PC Neuromodulation System and EndoSheath System. It operates primarily in Orangeburg, New York,...

See More

Key Turning Points

2nd Resistance Point 3.87
1st Resistance Point 3.86
Last Price 3.85
1st Support Level 3.83
2nd Support Level 3.81

See More

52-Week High 3.92
Last Price 3.85
Fibonacci 61.8% 3.01
Fibonacci 50% 2.74
Fibonacci 38.2% 2.46
52-Week Low 1.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar